EN-145
- Generic Name
- EN-145
MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies
Phase 2
Terminated
- Conditions
- Related Donors Donating PBSC to a Family MemberHealthy DonorsAcute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Ensoma
- Target Recruit Count
- 7
- Registration Number
- NCT04762875
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸Stanford Health Care, Stanford, California, United States
🇺🇸Mayo Clinic Rochester, Rochester, Minnesota, United States
MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- Surbhi Sidana, MD
- Target Recruit Count
- 25
- Registration Number
- NCT04552743
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath